Wang Yu-Hao, Wu Yu-Tung, Cheng Chi-Tung, Fu Chih-Yuan, Liao Chien-Hung, Chen Huan-Wu, Hsieh Chi-Hsun
Division of Trauma and Emergency Surgery, Department of Surgery, Chang Gung Memorial Hospital, No. 5, Fuxing St., Guishan Dist., Taoyuan City, 333, Taiwan.
Department of Medical Imaging & Intervention, Linkou Chang Gung Memorial Hospital, No. 5, Fuxing St., Guishan Dist., Taoyuan City, 333, Taiwan.
Eur J Trauma Emerg Surg. 2025 Jan 24;51(1):77. doi: 10.1007/s00068-024-02698-2.
This study investigates the risk of contrast-associated acute kidney injury (CA-AKI) in trauma patients, focusing on the impact of cumulative contrast medium doses.
A retrospective review was conducted at a level 1 trauma center (2019-2021). The study included patients who underwent intravascular contrast-enhanced examinations for torso trauma within 7 days post-injury. The total contrast medium volume within 7 days was calculated. Multivariate logistic regression (MLR) identified AKI risk factors.
Among the 264 patients, 7.2% (19/264) developed AKI, with 3.4% (9/264) classified as KDIGO stage 3. Approximately 42.8% of patients underwent at least two contrast-enhanced examinations. The mean total contrast medium given was 129.5mL (range 80-410 ml). Multiple logistic regression (MLR) analysis identified four independent risk factors for AKI: diabetes mellitus, initial eGFR < 30, use of inotropic agents, and contrast medium exposure. The odds ratio of AKI increased by 2.92 (95% CI 1.30-6.53) for every 100 ml increase in contrast dose. The contrast volume exposure only plays an important role in severe trauma patients (ISS ≥ 25). Moreover, when correlated with eGFR, the contrast medium exposure volume demonstrated better predictive ability for AKI with a best cut-off value of Contrast volume to eGFR ratio > 1.86.
While repetitive contrast-enhanced examinations are sometimes inevitable, they do come with costs. The CA-AKI risk increases as the amount of contrast medium accumulates in trauma patients who require repetitive examinations.
本研究调查创伤患者中与造影剂相关的急性肾损伤(CA-AKI)的风险,重点关注累积造影剂剂量的影响。
在一级创伤中心(2019 - 2021年)进行回顾性研究。该研究纳入了受伤后7天内接受躯干创伤血管内造影增强检查的患者。计算7天内的总造影剂体积。多因素逻辑回归(MLR)确定急性肾损伤的危险因素。
在264例患者中,7.2%(19/264)发生急性肾损伤,其中3.4%(9/264)为KDIGO 3期。约42.8%的患者至少接受了两次造影增强检查。给予的造影剂平均总量为129.5mL(范围80 - 410ml)。多因素逻辑回归(MLR)分析确定了急性肾损伤的四个独立危险因素:糖尿病、初始估算肾小球滤过率(eGFR)<30、使用血管活性药物和造影剂暴露。造影剂剂量每增加100ml,急性肾损伤的比值比增加2.92(95%置信区间1.30 - 6.53)。造影剂暴露量仅在严重创伤患者(损伤严重度评分[ISS]≥25)中起重要作用。此外,当与eGFR相关时,造影剂暴露量对急性肾损伤具有更好的预测能力,最佳截断值为造影剂体积与eGFR比值>1.86。
虽然有时重复造影增强检查不可避免,但确实存在代价。在需要重复检查的创伤患者中,随着造影剂用量的累积,CA-AKI风险增加。